Squarepoint’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
QOP
Squarepoint's CDLX Position: Q2 2026 in Review
Squarepoint opened a new position in Cardlytics (CDLX) in Q2 2026: 26,973 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #4173 among its holdings. This is a return to the name: Squarepoint previously reported a position in CDLX as recently as Q2 2025.
Squarepoint first reported a position in CDLX in Q2 2019 and has held it in 20 quarters since. The position peaked at $3.42M in Q2 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- Squarepoint held 26,973 shares of Cardlytics worth $121K as of Q2 2026.
- Cardlytics was a new Squarepoint position in Q2 2026.
- Cardlytics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4173 holding.
- Squarepoint first reported a position in Cardlytics in Q2 2019 and has held it in 20 quarters since.
- Squarepoint's Cardlytics position peaked at $3.42M in Q2 2021.
- 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.